keyword
MENU ▼
Read by QxMD icon Read
search

Ustekinumab crohn's

keyword
https://www.readbyqxmd.com/read/28204858/-ustekinumab-for-the-treatment-of-crohn-s-disease-uniti-im-uniti
#1
B Siegmund, S Nitschmann
No abstract text is available yet for this article.
February 15, 2017: Der Internist
https://www.readbyqxmd.com/read/28179246/legionella-pneumophila-pneumonia-possibly-due-to-ustekinumab-therapy-in-a-patient-with-crohn-s-disease
#2
Joaquín Borrás-Blasco, Xavier Cortes, Sergio Fernandez-Martinez, Elvira Casterá, Beatriz Antequera
PURPOSE: A case report of Legionella pneumophila pneumonia associated with off-label use of ustekinumab in a patient with Crohn's disease (CD) is presented. SUMMARY: A 57-year-old man with longstanding CD was hospitalized with a four-day history of fever (38.5 °C), dyspnea, left pleuritic pain, and weight loss (more than 6 kg) about six weeks after beginning treatment with ustekinumab, a human monoclonal antibody approved in the United States for two indications (plaque psoriasis and psoriatic arthritis) and currently under investigation as a potential treatment for CD and other inflammatory disorders...
February 15, 2017: American Journal of Health-system Pharmacy: AJHP
https://www.readbyqxmd.com/read/28175164/p594-ustekinumab-treatment-effectiveness-in-clinical-practice-a-multicentre-retrospective-review-of-long-term-outcomes-in-crohn-s-disease
#3
C R Rowan, A Alakkari, C Moran, J O'Connell, G Cullen, H Mulcahy, C O'Morain, D McNamara, J Leyden, P MacMathuna, A O'Toole, S Patchett, S McKiernan, D Kevans, G A Doherty, B Ryan
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175158/p626-ustekinumab-for-the-treatment-of-perianal-fistulas-in-patients-with-crohn-s-disease
#4
R Battat, T Bessissow, M Strohl, U Kopylov, A Bitton, A Cohen, E Seidman, W Afif
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175147/p549-effect-of-maintenance-ustekinumab-on-corticosteroid-free-clinical-outcomes-in-patients-with-crohn-s-disease
#5
B G Feagan, C Gasink, P Pollack, D Jacobstein, L-L Gao, J Johanns, Y Miao, S Targan, S Ghosh
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175098/p360-trough-levels-and-antibodies-to-ustekinumab-are-not-correlated-to-response-to-ustekinumab-treatment-in-crohn-s-disease-patients
#6
P Claire, B Severine, D Nicolas, N Maria, D Pierre, B Julien, G Romain, B Medina, L Myriam, P Benjamin
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28174962/dop053-the-fecal-microbiome-as-a-tool-for-monitoring-and-predicting-response-outcomes-in-ustekinumab-treated-anti-tnf%C3%AE-refractory-crohn-s-disease-patients-results-from-the-certifi-study
#7
M K Doherty, C Koumpouras, S E Telesco, C Monast, C Brodmerkel, P D Schloss
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28174941/dop052-molecular-response-to-ustekinumab-in-moderate-to-severe-crohn-s-disease-by-serum-protein-and-biopsy-gene-expression-analysis-results-from-ustekinumab-phase-3-studies
#8
K Li, K Hayden, E Wadman, S Bhagat, S Emrich, D Jacobstein, C Gasink, C Brodmerkel
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28174928/dop046-genome-wide-association-study-of-baseline-disease-characteristics-and-response-to-ustekinumab-in-moderate-to-severe-crohn-s-disease
#9
A Hart, K Li, C Gasink, D Jacobstein, C Brodmerkel
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28174927/dop027-long-term-efficacy-and-safety-of-ustekinumab-in-refractory-crohn-s-disease-patients-a-multicenter-retrospective-experience
#10
P Wils, Y Bouhnik, P Michetti, B Flourie, H Brixi, A Bourrier, M Allez, B Duclos, M Serrero, A Buisson, A Amiot, M Fumery, X Roblin, L Peyrin-Biroulet, J Filippi, G Bouguen, V Abitbol, B Coffin, M Simon, D Laharie, B Pariente
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28173013/p597-ustekinumab-use-in-crohn-s-disease-a-tertiary-centre-experience
#11
A Greenup, G Rosenfeld, B Bressler
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172810/p625-ustekinumab-use-in-crohn-s-disease-effectiveness-of-dose-escalation
#12
A Greenup, G Rosenfeld, B Bressler
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172686/op010-long-term-efficacy-and-safety-of-ustekinumab-for-crohn-s-disease-results-from-im-uniti-long-term-extension-through-2-years
#13
W Sandborn, P Rutgeerts, C Gasink, D Jacobstein, L-L Gao, J Johanns, B Sands, S B Hanauer, S Targan, S Ghosh, W J S de Villiers, J-F Colombel, B G Feagan
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172546/p588-ustekinumab-for-the-treatment-of-crohn-s-disease-patients-with-tnf-antagonist-induced-psoriasis-real-life-experience-from-a-tertiary-referral-center-through-week-54
#14
T Kuehbacher, R Abu Hashem, N Langel, S Schreiber, O Drvarov
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172536/p465-efficacy-of-ustekinumab-for-induction-and-maintenance-of-histological-healing-in-patients-with-crohn-s-disease
#15
K Li, D Chan, P Pollack, D Jacobstein, C Brodmerkel, C Gasink, B G Feagan, W Sandborn, P Rutgeerts, G De Hertogh
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172459/p305-indirect-comparison-of-two-novel-biologics-for-the-treatment-of-crohn-s-disease-network-meta-analysis-of-ustekinumab-vs-vedolizumab
#16
G Hather, R Curtis, K Minda, I A Zouraq, J M Khalid
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28140549/treatment-options-for-pyoderma-gangrenosum
#17
REVIEW
Sven R Quist, Luise Kraas
Pyoderma gangrenosum (PG) is an orphan disease. While research on such disorders is based on only few randomized multicenter as well as retrospective studies, most of the data comes from case series of small patient groups. Apart from topical and intralesional therapeutic options for early stages and mild disease courses, treatment predominantly involves systemic therapeutic agents. Besides systemic corticosteroids and cyclosporine A (CsA), options also include intravenous immunoglobulins (IVIG) and biologics such as the TNFα inhibitors infliximab, adalimumab, and etanercept; the interleukin (IL) 12/23 antibody ustekinumab; the IL-1 receptor antagonist anakinra; and the IL-1β antibody canakinumab...
January 2017: Journal der Deutschen Dermatologischen Gesellschaft, Journal of the German Society of Dermatology: JDDG
https://www.readbyqxmd.com/read/28140542/therapieoptionen-beim-pyoderma-gangraenosum
#18
REVIEW
Sven R Quist, Luise Kraas
Das Pyoderma gangraenosum (PG) gehört zu den orphan diseases, deren Erforschung sich lediglich auf einzelne, randomisierte, multizentrische sowie retrospektive Studien stützen kann und überwiegend auf Fallserien an kleinen Patientenkollektiven beruht. Die Therapie basiert neben topischen und lokal intraläsionalen Therapieoptionen, bei initialem und leichtem Krankheitsverlauf, insbesondere auf der Gabe von Systemtherapeutika. Diese beinhaltet neben den systemischen Glukokortikosteroiden und Ciclosporin A (CsA) auch Biologika wie intravenöses Immunglobulin G (IVIG), die TNFα-Inhibitoren Infliximab, Adalimumab und Etanercept, den IL-12/23-Antikörper Ustekinumab, den Interleukin-1-Rezeptorantagonist Anakinra und den Interleukin-1β-Antikörper Canakinumab...
January 2017: Journal der Deutschen Dermatologischen Gesellschaft, Journal of the German Society of Dermatology: JDDG
https://www.readbyqxmd.com/read/28026835/ustekinumab-stelara-for-crohn-s-disease
#19
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
January 2, 2017: Medical Letter on Drugs and Therapeutics
https://www.readbyqxmd.com/read/28004853/ustekinumab-therapy-for-crohn-s-disease-during-pregnancy-a-case-report-and-review-of-the-literature
#20
X Cortes, J Borrás-Blasco, B Antequera, S Fernandez-Martinez, E Casterá, S Martin, J R Molés
WHAT IS KNOWN AND OBJECTIVES: The safety of continued ustekinumab (UST) therapy during pregnancy remains unclear in patients with Crohn's disease (CD). There are no meta-analysis reports of exposure to UST during pregnancy. The objective was to describe a case of a pregnant patient with CD who was successfully treated with UST maintenance therapy throughout the pregnancy and delivered a baby boy without any congenital malformations, neurological abnormalities or birth defects. CASE SUMMARY: A 37-year-old patient with CD treated with UST became pregnant...
December 22, 2016: Journal of Clinical Pharmacy and Therapeutics
keyword
keyword
44834
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"